University of Coruna   Report issue

Academic/Hospital Phase 3
Founded: A Coruña Spain (1990)

Organization Overview

First Clinical Trial
2011
NCT01314859
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

A Coruña University Complex | Complejo Hospitalario Universitario A Coruña | Complejo Hospitalario Universitario A Coruna | Complexo Hospitalario Universitario de Santiago | Dr. FRANCISCO J. BLANCO-GARCIA | Hospital del Barbanza; Ribeira, A Coruna, Spain | H. Teresa Herrera - Coruna | Instituto de Investigacion Biomedica de A Coruna | Research Center on Information and Communication Technologies (CITIC) | Universidade da Coruña | Universidade da Coruña (UDC) | University of A Coruña

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 3)

Cardiac Output, Low (Phase 3)

Obstetric Labor, Premature (Phase 3)

Premature Birth (Phase 3)

Prostatic Neoplasms (Phase 3)

Recurrence (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 6